{"id":11862,"date":"2025-07-30T07:27:27","date_gmt":"2025-07-30T07:27:27","guid":{"rendered":"https:\/\/mdxcro.com\/services\/affaires-reglementaires-documentation-technique\/"},"modified":"2026-06-24T09:50:32","modified_gmt":"2026-06-24T09:50:32","slug":"affaires-reglementaires-documentation-technique","status":"publish","type":"service","link":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/","title":{"rendered":"Affaires r\u00e9glementaires et documentation technique"},"content":{"rendered":"\n<section id=\"block_08af6821f4c886059efa18ffbe966e27\" class=\"hero\">\n    <div class=\"hero--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/RA-technical-documentations-MDx-CRO.webp\" fetchpriority=\"high\" class=\"no-lazy\" alt=\"\" \/>\n    <\/div>\n        <div class=\"container\">\n                <div class=\"content\">\n                                    <h1 class=\"title\">Affaires r\u00e9glementaires et documentation technique pour garantir une approbation mondiale<\/h1>\n            \n                            <div class=\"description\"><p><span style=\"font-weight: 400;\">Naviguez avec confiance dans les parcours r\u00e9glementaires complexes. <\/span><b>Notre \u00e9quipe d\u2019anciens experts d\u2019organismes notifi\u00e9s, de sp\u00e9cialistes de la r\u00e9glementation et de r\u00e9dacteurs m\u00e9dicaux<\/b><span style=\"font-weight: 400;\"> fournit une documentation technique conforme et des conseils r\u00e9glementaires strat\u00e9giques pour le RDIV, le RDM, la FDA, l\u2019UKCA et les march\u00e9s mondiaux.<\/span><\/p>\n<\/div>\n            \n                            <div class=\"button-wrapper\">\n                                            <a href=\"https:\/\/mdxcro.com\/fr\/contact\/?utm_source=ra_tech_doc\" class=\"button bouton--par d\u00e9faut\" target=\"_self\">\n                            R\u00e9server une \u00e9valuation r\u00e9glementaire                        <\/a>\n                                            <a href=\"https:\/\/mdxcro.com\/fr\/contact\/?utm_source=ra_tech_doc\" class=\"button bouton--secondaire\" target=\"_self\">\n                            Soumettez votre dossier d\u2019AR d\u00e8s aujourd\u2019hui                        <\/a>\n                                    <\/div>\n                            <\/div>\n            <\/div>\n<\/section>\n\n<section id=\"block_1a6de578556cf824000307b5d975eb2e\" class=\"text-image\" style=\"padding-top: var(--wp--preset--spacing--regular); padding-bottom: var(--wp--preset--spacing--regular); \">\n        <div class=\"container\">\n        <div class=\"grid\">\n            <div class=\"column column--content\"><div class=\"text\"><h2 class=\"title\">L\u2019excellence <span class=\"blue-highlight\"> r\u00e9glementaire <\/span> pour les DIV et les dispositifs m\u00e9dicaux<\/h2><div class=\"description wysiwyg\"><p><span style=\"font-weight: 400\">Chez MDx CRO, nous transformons les d\u00e9fis r\u00e9glementaires en avantages concurrentiels. Que vous naviguiez dans la   <\/span><a href=\"https:\/\/mdxcro.com\/sectors\/ivd-end-to-end\/\"><span style=\"font-weight: 400\">transition vers le RDIV<\/span><\/a><span style=\"font-weight: 400\">, pr\u00e9pariez la documentation technique RDM ou planifiiez une strat\u00e9gie r\u00e9glementaire mondiale, notre \u00e9quipe fournit des conseils d\u2019experts et un soutien pratique tout au long du cycle de vie du produit.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Nos <\/span><span style=\"font-weight: 400\">services d\u2019affaires r\u00e9glementaires et de documentation technique<\/span><span style=\"font-weight: 400\"> couvrent toutes les classes de dispositifs et cat\u00e9gories de risques \u2014 des dispositifs m\u00e9dicaux de classe I aux DIV de classe D \u2014 garantissant que vos dossiers de soumission sont scientifiquement fond\u00e9s, techniquement pr\u00e9cis et pleinement align\u00e9s sur les exigences r\u00e9glementaires.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Dirig\u00e9s par d\u2019anciens examinateurs d\u2019organismes notifi\u00e9s et d\u2019autorit\u00e9s r\u00e9glementaires, nous apportons l\u2019expertise dont vous avez besoin pour obtenir des r\u00e9sultats conformes, efficaces et fructueux pour votre technologie m\u00e9dicale.<\/span><\/p>\n<\/div><\/div><\/div>                            <div class=\"column column--image\"><img decoding=\"async\" class=\"image\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/regulatory-excelence.jpg\" alt=\"Advanced healthcare professionals discussing innovative MedTech solutions on a tablet in a modern clinical setting.\"  \/><\/div>                    <\/div>\n    <\/div>\n<\/section>\n\n<section id=\"block_9da0dcfbc0907fda7d8861efa39ace31\" class=\"sticky-navbar\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n                <div class=\"container\">\n                <ul class=\"list\">\n                    <li class=\"item\">\n                            <a href=\"#RegulatoryStrategy\" class=\"link\" target=\"\"> \n                    Strat\u00e9gie r\u00e9glementaire \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#Technicaldocumentation\" class=\"link\" target=\"\"> \n                    Documentation technique \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#PerformanceEvaluation\" class=\"link\" target=\"\"> \n                    \u00c9valuation des performances \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#RegulatorySubmissions\" class=\"link\" target=\"\"> \n                    Soumissions r\u00e9glementaires \n                <\/a>\n                                <li class=\"item\">\n                            <a href=\"#RepresentativeServices\" class=\"link\" target=\"\"> \n                    Services de repr\u00e9sentation \n                <\/a>\n                            <\/ul>\n                \n    <\/div>\n<\/section>\n\n<section id=\"RegulatoryStrategy\" class=\"content-columns content-columns--three-columns \" style=\"padding-top: var(--wp--preset--spacing--regular); padding-bottom: var(--wp--preset--spacing--regular); \">\n        <div class=\"container\">\n                    <div class=\"content\">\n                                    <h2 class=\"title\">Services complets de documentation <span class=\"blue-highlight\"> r\u00e9glementaire <\/span> et <span class=\"blue-highlight\"> technique <\/span><\/h2>\n                                                    <div class=\"description wysiwyg\">\n                        <p><b>Strat\u00e9gie et veille r\u00e9glementaires<\/b><\/p>\n                    <\/div>\n                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">D\u00e9termination du parcours r\u00e9glementaire mondial<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gies d\u2019acc\u00e8s au march\u00e9 pour l\u2019UE (RDIV\/RDM), les \u00c9tats-Unis (FDA), le Royaume-Uni (UKCA) et le reste du monde<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c9valuation de la classification des dispositifs<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">S\u00e9lection de la proc\u00e9dure d\u2019\u00e9valuation de la conformit\u00e9<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Surveillance strat\u00e9gique des consid\u00e9rations r\u00e9glementaires tout au long du d\u00e9veloppement<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Veille r\u00e9glementaire<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Suivi cibl\u00e9 de l\u2019\u00e9volution des r\u00e9glementations et des directives<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Interpr\u00e9tation des exigences r\u00e9glementaires pour votre dispositif sp\u00e9cifique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Analyse d\u2019impact des changements r\u00e9glementaires<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Analyse prospective et alerte pr\u00e9coce sur les changements \u00e0 venir<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Pr\u00e9-soumission et avis scientifique<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration aux consultations avec les organismes notifi\u00e9s (dialogues structur\u00e9s)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">R\u00e9unions de pr\u00e9-soumission \u00e0 la FDA<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Consultation de l\u2019EMA pour les diagnostics compagnons<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Avis scientifiques des autorit\u00e9s comp\u00e9tentes<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gies pour le MDCG et les panels d\u2019experts<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n<section id=\"Technicaldocumentation\" class=\"content-columns content-columns--three-columns content-columns--background-white\" style=\"padding-top: var(--wp--preset--spacing--small); padding-bottom: var(--wp--preset--spacing--regular); \">\n    \t<div \n\t\tclass=\"component-top-icon\"\n\t\tstyle=\"--component-top-icon-height: 70px\"\n\t>\n\t\t<img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX-icon.svg\" alt=\"\" \/>\n\t<\/div>\n\t    <div class=\"container\">\n                    <div class=\"content\">\n                                                    <div class=\"description wysiwyg\">\n                        <p><b>\u00c9laboration de la<\/b> <strong><span class=\"blue-highlight\">documentation technique <\/span><\/strong> <\/p>\n                    <\/div>\n                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Cr\u00e9ation du dossier technique et du dossier de conception<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">R\u00e9daction et compilation compl\u00e8tes de la documentation technique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Structure et contenu conformes au RDIV\/RDM<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c9valuations des lacunes par rapport aux r\u00e9glementations actuelles<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Remise \u00e0 niveau et mises \u00e0 jour des dossiers techniques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Soutien \u00e0 la transition des dispositifs h\u00e9rit\u00e9s<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Documentation GSPR<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c9valuation de la conformit\u00e9 et documentation GSPR<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Documentation de conformit\u00e9 aux normes<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Revues de l\u2019\u00e9tat de l\u2019art<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Planification de l\u2019\u00e9valuation clinique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Documentation de l\u2019\u00e9valuation b\u00e9n\u00e9fice\/risque<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Gestion des risques<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><a href=\"https:\/\/mdxcro.com\/fr\/?post_type=service&amp;p=11858\"><span style=\"font-weight: 400\">Gestion des risques conforme \u00e0 l\u2019ISO 14971<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Dossiers et rapports de gestion des risques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Planification de la gestion des risques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Suivi des risques en production et post-production<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Documentation de l\u2019analyse b\u00e9n\u00e9fice\/risque<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c9valuations des risques li\u00e9s \u00e0 l\u2019aptitude \u00e0 l\u2019utilisation<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n<section id=\"PerformanceEvaluation\" class=\"content-columns content-columns--three-columns content-columns--background-blue\" style=\"padding-top: var(--wp--preset--spacing--small); padding-bottom: var(--wp--preset--spacing--small); \">\n        <div class=\"container\">\n                    <div class=\"content\">\n                                                    <div class=\"description wysiwyg\">\n                        <p><strong>\u00c9valuation des performances et preuves cliniques<\/strong><\/p>\n                    <\/div>\n                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Plans et rapports d\u2019\u00e9valuation des performances<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">PEP et PER conformes au RDIV<\/span><\/li>\n<li style=\"font-weight: 400\"><a href=\"https:\/\/mdxcro.com\/fr\/?post_type=service&amp;p=11850\"><span style=\"font-weight: 400\">Rapports de validit\u00e9 scientifique<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><a href=\"https:\/\/mdxcro.com\/services\/ivd-analytical-studies\/\"><span style=\"font-weight: 400\">\u00c9valuation des performances analytiques<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><a href=\"https:\/\/mdxcro.com\/services\/ivd-clinical-studies\/\"><span style=\"font-weight: 400\">\u00c9valuation des performances cliniques<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Revue de la litt\u00e9rature et compilation<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">D\u00e9termination de l\u2019\u00e9tat de l\u2019art<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">\u00c9valuation clinique<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Plans d\u2019\u00e9valuation clinique (PEC) et rapports (REC)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Revues de la litt\u00e9rature et \u00e9valuations<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">D\u00e9termination de l\u2019\u00e9tat de l\u2019art<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Analyses des lacunes en mati\u00e8re de preuves cliniques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gie relative aux preuves cliniques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Remise \u00e0 niveau du REC pour la conformit\u00e9 au RDM<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Planification de la surveillance apr\u00e8s commercialisation<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Plans et proc\u00e9dures de SAC align\u00e9s sur le RDIV\/RDM<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Rapports de SAC et \u00e9laboration des PSUR<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Planification du PMPF et du PMCF<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Proc\u00e9dures d\u2019analyse des tendances<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Vigilance et \u00e9valuation des \u00e9v\u00e9nements d\u00e9clarables<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n<section id=\"RegulatorySubmissions\" class=\"content-columns content-columns--three-columns content-columns--background-white\" style=\"padding-top: var(--wp--preset--spacing--small); padding-bottom: var(--wp--preset--spacing--small); \">\n    \t<div \n\t\tclass=\"component-top-icon\"\n\t\tstyle=\"--component-top-icon-height: 70px\"\n\t>\n\t\t<img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/Vector.png\" alt=\"\" \/>\n\t<\/div>\n\t    <div class=\"container\">\n                    <div class=\"content\">\n                                                    <div class=\"description wysiwyg\">\n                        <p><b>Soumissions r\u00e9glementaires et communications avec les autorit\u00e9s<\/b><\/p>\n                    <\/div>\n                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Soumissions aux organismes notifi\u00e9s<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration compl\u00e8te du dossier de soumission<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Gestion des r\u00e9ponses aux lettres de d\u00e9ficience<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Gestion de la communication avec les organismes notifi\u00e9s<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Revues et audits blancs d\u2019organismes notifi\u00e9s<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Rapports d\u2019\u00e9valuation de la documentation technique<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Interactions avec les autorit\u00e9s comp\u00e9tentes et les organismes r\u00e9glementaires<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Processus de consultation de l\u2019EMA pour les diagnostics compagnons<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration de la soumission au panel d\u2019experts du MDCG pour les dispositifs \u00e0 haut risque<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Communications avec les autorit\u00e9s comp\u00e9tentes<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Gestion des r\u00e9ponses aux demandes r\u00e9glementaires<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration aux inspections r\u00e9glementaires<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white-frost\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Soumissions FDA, UKCA et mondiales<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Pr\u00e9paration de la soumission FDA 510(k)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Demandes FDA De Novo et PMA<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Dossiers techniques pour le marquage UKCA<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Demandes de licence aupr\u00e8s de Sant\u00e9 Canada<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gies d\u2019enregistrement mondial et soumissions<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n            <\/div>\n<\/section>\n\n<section id=\"RepresentativeServices\" class=\"content-columns content-columns--three-columns \" style=\"padding-top: var(--wp--preset--spacing--small); padding-bottom: var(--wp--preset--spacing--small); \">\n        <div class=\"container\">\n                    <div class=\"content\">\n                                                    <div class=\"description wysiwyg\">\n                        <p><b>Services de mandataire et op\u00e9rations r\u00e9glementaires<\/b><\/p>\n                    <\/div>\n                            <\/div>\n        \n                    <div class=\"grid\">\n                                                        <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Mandataires europ\u00e9ens (Repr\u00e9sentants autoris\u00e9s)<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Services de mandataire dans l\u2019UE<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Services de personne responsable au Royaume-Uni<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Promoteur d\u2019\u00e9tude d\u00e9l\u00e9gu\u00e9 <\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Suivi de la conformit\u00e9 r\u00e9glementaire<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Soutien \u00e0 la d\u00e9claration de vigilance<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Enregistrement EUDAMED et IUD<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Enregistrement et gestion EUDAMED<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Enregistrement des op\u00e9rateurs \u00e9conomiques<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Conformit\u00e9 et mise en \u0153uvre de l\u2019IUD<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Strat\u00e9gie d\u2019attribution de l\u2019IUD-ID de base<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Enregistrement des produits et des certificats<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                                            <div class=\"card card--background-white\">\n                                            <div class=\"top\">\n                                                                                        <h3 class=\"headline\">Contr\u00f4le documentaire et int\u00e9gration du SMQ<\/h3>\n                                                                                        <div class=\"teaser wysiwyg\"><ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Gestion du cycle de vie de la documentation technique<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Int\u00e9gration des exigences r\u00e9glementaires au SMQ<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Contr\u00f4le des documents et gestion des versions<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Maintenance des dossiers r\u00e9glementaires<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c9laboration de SOP pour les processus r\u00e9glementaires<\/span><\/li>\n<\/ul>\n<\/div>\n                                                    <\/div>\n                                                                    <\/div>\n                                                <\/div>\n                  \n          \n\n                    <div class=\"button-wrapper\">\n                                    <a href=\"https:\/\/mdxcro.com\/services\/representative-services\/\" class=\"button bouton--par d\u00e9faut\" target=\"_self\">\n                        Explorer les services de mandataire                    <\/a>\n                            <\/div>\n            <\/div>\n<\/section>\n<section class=\"table\"><div class=\"container\"><div class=\"headline\">Pourquoi choisir MDx pour les affaires r\u00e9glementaires et la documentation technique ? <br \/>Notre expertise diff\u00e9renci\u00e9e<\/div><div class=\"table-wrapper\"><div class=\"feature-column-wrapper\"><table class=\"feature-table\"><thead><tr><th class=\"feature-column\">Capacit\u00e9<\/th><\/tr><\/thead><tbody><tr><td class=\"feature-cell\"><strong>Anciens experts d\u2019organismes notifi\u00e9s<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Revues blanches d\u2019ON<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Sp\u00e9cialisation RDIV\/RDM<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>AR et Clinique combin\u00e9s<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Mod\u00e8les sp\u00e9cifiques aux dispositifs<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Connaissance des domaines th\u00e9rapeutiques<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Expertise GSPR\/Normes<\/strong><\/td><\/tr><tr><td class=\"feature-cell\"><strong>Int\u00e9gration de la strat\u00e9gie mondiale<\/strong><\/td><\/tr><\/tbody><\/table><\/div><div class=\"scrollable-columns-wrapper\"><table class=\"comparison-table\"><thead><tr><th class=\"column highlight\">MDx CRO<\/th><th class=\"column\">CRO typiques<\/th><\/tr><\/thead><tbody><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Provenant des principaux ON de l\u2019UE, dont BSI<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Limit\u00e9e ou nulle<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">V\u00e9ritables anciens examinateurs d\u2019ON<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Souvent par des consultants sans exp\u00e9rience en ON<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Sp\u00e9cialistes des r\u00e9glementations actuelles<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Souvent en transition depuis les anciennes directives<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Services int\u00e9gr\u00e9s<\/td><td class=\"cell\"><img decoding=\"async\" width=\"22\" height=\"22\" class=\"wp-image-7062 icon\" style=\"width: 22px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/x-1.svg\" alt=\"\">D\u00e9partements g\u00e9n\u00e9ralement s\u00e9par\u00e9s<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Personnalis\u00e9s pour votre technologie<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Mod\u00e8les g\u00e9n\u00e9riques<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Compr\u00e9hension clinique approfondie<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Approche g\u00e9n\u00e9ralis\u00e9e<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">Sp\u00e9cialistes des normes au sein du personnel<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Connaissances de base uniquement<\/td><\/tr><tr><td class=\"cell highlight\"><img decoding=\"async\" width=\"20\" height=\"17\" class=\"wp-image-7058 icon\" style=\"width: 20px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" alt=\"\">UE, Royaume-Uni, \u00c9tats-Unis et monde<\/td><td class=\"cell\"><img decoding=\"async\" width=\"24\" height=\"24\" class=\"wp-image-7068 icon\" style=\"width: 24px;\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/half-half-blue.svg\" alt=\"\">Expertise sp\u00e9cifique \u00e0 une r\u00e9gion<\/td><\/tr><\/tbody><\/table><\/div><\/div><\/div><\/section>\n<section class=\"key-stats\"  style=\"\">\n  \t<div \n\t\tclass=\"component-top-icon\"\n\t\tstyle=\"--component-top-icon-height: 70px\"\n\t>\n\t\t<img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX-icon.svg\" alt=\"\" \/>\n\t<\/div>\n\t  <div class=\"container\">\n          <div class=\"headline\">Indicateurs de r\u00e9ussite<\/div>\n    \n    <div class=\"main-wrapper\">\n              <div class=\"box-grid\">\n                                    <div class=\"box\">\n                                  <div class=\"value\">500+<\/div>\n                                                  <div class=\"legend\">dispositifs mis sur le march\u00e9 avec succ\u00e8s sous RDIV\/RDM<\/div>\n                              <\/div>\n                                                <div class=\"box\">\n                                  <div class=\"value\">100%<\/div>\n                                                  <div class=\"legend\">taux d\u2019acceptation de la documentation technique avec la m\u00e9thodologie structur\u00e9e de MDx<\/div>\n                              <\/div>\n                                                <div class=\"box\">\n                                  <div class=\"value\">30%<\/div>\n                                                  <div class=\"legend\">r\u00e9duction moyenne des cycles de r\u00e9vision des organismes notifi\u00e9s<\/div>\n                              <\/div>\n                                                <div class=\"box\">\n                                  <div class=\"value\">15+<\/div>\n                                                  <div class=\"legend\">Organismes notifi\u00e9s et autorit\u00e9s comp\u00e9tentes engag\u00e9s sur le RDIV\/RDM<\/div>\n                              <\/div>\n                              <\/div>\n      \n          <\/div>\n\n    <div class=\"data\">\n              <div class=\"description wysiwyg\">\n          <p>Anciens examinateurs de <strong>BSI, T\u00dcV S\u00dcD<\/strong> au sein du personnel<\/p>\n<p><strong>Plusieurs approbations<\/strong> de dispositifs de premier ordre sous RDIV\/RDM<\/p>\n<p><strong>Documentation technique Annexe II\/III<\/strong> r\u00e9dig\u00e9e et remise \u00e0 niveau pour toutes les classes de risques<\/p>\n        <\/div>\n      \n          <\/div>\n  <\/div>\n<\/section>\n\n<section id=\"block_a2711ff941f7284a25980c4e984dc87d\" class=\"case-study-details\" style=\"background-image: url(&#039;https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/CRO-medical-devices-services-MDx-CRO.webp&#039;);\">\n    \n    \n    <div class=\"container\">\n                    <div class=\"headline\">\u00c9tudes de Cas<\/div>\n        \n                    <div class=\"slider\">\n                                    <div class=\"slider-item\" data-button-url=\"https:\/\/mdxcro.com\/fr\/case-studies\/ivdr-technical-documentation-remediation\/\">\n                                                <div class=\"subtitle\">IVDR Technical Documentation Remediation<\/div>\n                                            <div class=\"list\">\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/challenge.svg\" alt=\"Challenge\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Challenge <\/span>\n                                        <p><span style=\"font-weight: 400;\">A global IVD manufacturer needed to transition 15 assays from IVDD to IVDR within 12 months, with significant gaps in technical documentation and clinical evidence.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/solution.svg\" alt=\"Solution\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Solution <\/span>\n                                        <p><span style=\"font-weight: 400;\">MDx implemented our structured Technical Documentation Remediation Process, with specialized teams for performance evaluation, risk management, and labeling compliance.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/result.svg\" alt=\"Result\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Result <\/span>\n                                        <p><span style=\"font-weight: 400;\">All 15 assays successfully certified under IVDR with a single round of Notified Body review, completed 2 months ahead of deadline.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                    <\/div>\n                                    <div class=\"slider-item\" data-button-url=\"https:\/\/mdxcro.com\/fr\/case-studies\/complex-device-classification-strategy\/\">\n                                                <div class=\"subtitle\">Complex Device Classification &#038; Strategy<\/div>\n                                            <div class=\"list\">\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/challenge.svg\" alt=\"Challenge\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Challenge <\/span>\n                                        <p><span style=\"font-weight: 400;\">A novel combination product with both medical device and IVD components required a clear regulatory pathway under both MDR and IVDR.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/solution.svg\" alt=\"Solution\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Solution <\/span>\n                                        <p><span style=\"font-weight: 400;\">MDx conducted a comprehensive classification assessment, consulted with authorities, and developed an integrated regulatory strategy leveraging both frameworks.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                    <div class=\"list-item\">\n                                                                <div class=\"icon\">\n                                    <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/result.svg\" alt=\"Result\" \/>\n                                <\/div>\n                                                                <div class=\"content\">\n                                    <div class=\"wrapper\">\n                                        <span class=\"title\"> Result <\/span>\n                                        <p><span style=\"font-weight: 400;\">Client secured clarification on primary regulation, optimized testing requirements, and reduced time-to-market by 6 months.<\/span><\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                    <\/div>\n                            <\/div>\n        \n        <div class=\"footer\">\n            <div class=\"slider-dots\"><\/div>\n            <div class=\"button-wrapper\">\n                <a href=\"\/resources\/?category=case-studies\" class=\"button button--tertiary\">View Case Studies<\/a>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n<section id=\"block_e8a8454f182db9fd7da13302bebeb90c\" class=\"flip-cards flip-cards--three-columns flip-cards--bg-white\" style=\"\">\n            <div class=\"container\">\n        <div class=\"content\">\n            \n                            <h2 class=\"title\">Notre processus de documentation technique<\/h2>\n            \n            \n                    <\/div>\n\n                    <div class=\"grid\">\n                                    <div class=\"card card--background-white-frost card--value\"\n                                                  >\n                        \n                                                                                    <div class=\"circle\">\n                                    <div class=\"value\">1.<\/div>\n                                <\/div>\n                                                    \n                        <div class=\"front\">\u00c9valuation et analyse des lacunes<\/div>\n                        <div class=\"back\"><ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Examen complet de la documentation existante<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Analyse des lacunes par rapport aux r\u00e9glementations cibles<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">\u00c9laboration de la strat\u00e9gie r\u00e9glementaire<\/span><\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-blue card--value\"\n                                                  >\n                        \n                                                                                    <div class=\"circle\">\n                                    <div class=\"value\">2.<\/div>\n                                <\/div>\n                                                    \n                        <div class=\"front\">Planification de la remise \u00e0 niveau<\/div>\n                        <div class=\"back\"><ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">\u00c9laboration d\u2019un plan d\u2019action prioritaire<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Allocation des ressources et calendriers<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Cr\u00e9ation de mod\u00e8les et planification du contenu<\/span><\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-black card--value\"\n                                                  >\n                        \n                                                                                    <div class=\"circle\">\n                                    <div class=\"value\">3.<\/div>\n                                <\/div>\n                                                    \n                        <div class=\"front\">D\u00e9veloppement du contenu<\/div>\n                        <div class=\"back\"><ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">R\u00e9daction technique par des experts du domaine<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Compilation et analyse des preuves<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Renvois et v\u00e9rifications de la coh\u00e9rence<\/span><\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-blue card--value\"\n                                                  >\n                        \n                                                                                    <div class=\"circle\">\n                                    <div class=\"value\">4.<\/div>\n                                <\/div>\n                                                    \n                        <div class=\"front\">Revue de qualit\u00e9<\/div>\n                        <div class=\"back\"><ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Processus de contr\u00f4le qualit\u00e9 en plusieurs \u00e9tapes<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Revue blanche d\u2019organisme notifi\u00e9<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">V\u00e9rification de la conformit\u00e9<\/span><\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--background-white-frost card--value\"\n                                                  >\n                        \n                                                                                    <div class=\"circle\">\n                                    <div class=\"value\">5.<\/div>\n                                <\/div>\n                                                    \n                        <div class=\"front\">Soumission et soutien<\/div>\n                        <div class=\"back\"><ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Pr\u00e9paration du dossier de soumission<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Gestion de la communication avec l\u2019organisme notifi\u00e9<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Coordination des r\u00e9ponses aux d\u00e9ficiences<\/span><\/li>\n<\/ul>\n<\/div>\n                    <\/div>\n                                    <div class=\"card card--has-bg-image card--image-only\"\n                         style=\"background-image: url(&#039;https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/logo-for-cards-blue-scaled.png&#039;);\"                         >\n                        \n                                                                            \n                        <div class=\"front\"><\/div>\n                        <div class=\"back\"><\/div>\n                    <\/div>\n                            <\/div>\n        \n            <\/div>\n<\/section>\n<section id=\"block_a1a3ebb7f9d0364c3fcd670c4cbc2714\" class=\"testimonials\" style=\"background-image: url(&#039;https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/regulatory-cpmpliance-technical-documentation-MDx-CRO.webp&#039;);\">\n        <div class=\"testimonials--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/regulatory-cpmpliance-technical-documentation-MDx-CRO.webp\" alt=\"\" \/>\n    <\/div>\n    <div class=\"container\">\n                    <div class=\"headline\">T\u00e9moignages clients<\/div>\n        \n                    <div class=\"slider\">\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0MDx&rsquo;s regulatory team provided exceptional technical documentation support for our IVDR submission. Their former Notified Body expertise was evident in the quality of the documentation, which passed review with no major findings.\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                Regulatory Affairs Director                                                                 <br>\n                                Top 10 Global IVD Manufacturer                                        \n                            <\/p>\n                                            <\/div>\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0The mock Notified Body review conducted by MDx identified critical gaps that would have certainly delayed our certification. Their remediation plan was precise and effective, saving us months of back-and-forth with our actua lNotified Body.\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                Quality and Regulatory Manager                                                                 <br>\n                                European Medical Device Startup                                        \n                            <\/p>\n                                            <\/div>\n                                    <div class=\"slider-item\">\n                                                    <p class=\"quote\">\u00ab\u00a0MDx helped us turn a scattered set of design and test reports into a clear Annex II\/III technical file. They were practical and fast, and their guidance on Notified Body expectations kept our questions to a minimum.\u00a0\u00bb<\/p>\n                                                                            <p class=\"author\">\n                                Head of Regulatory Affairs                                                                <br>\n                                European Molecular Diagnostics Company                                        \n                            <\/p>\n                                            <\/div>\n                            <\/div>\n        \n        <div class=\"footer\">\n            <div class=\"slider-dots\"><\/div>\n            <div class=\"button-wrapper\">\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n<section id=\"block_3038c426d6c5fdd23a5a80d049a33b9c\" class=\"faqs\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n    <div class=\"container\">\n    <div class=\"content\">\n      <div class=\"column\">\n                  <h2 class=\"headline\">Foire aux questions<\/h2>\n                          <a class=\"button bouton--par d\u00e9faut\" href=\"https:\/\/mdxcro.com\/fr\/contact\/\" target=\"\">\n            Posez-nous une question          <\/a>\n              <\/div>\n      <div class=\"column\">\n                  <ul class=\"faq-list\">\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Combien de temps faut-il g\u00e9n\u00e9ralement pour remettre \u00e0 niveau la documentation technique pour la conformit\u00e9 RDM\/RDIV ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Les d\u00e9lais varient en fonction de la classe du dispositif et de la maturit\u00e9 de la documentation, mais se situent g\u00e9n\u00e9ralement entre 3 et 8 mois pour une remise \u00e0 niveau compl\u00e8te de la documentation technique. Notre phase d\u2019\u00e9valuation fournit un calendrier pr\u00e9cis pour votre produit sp\u00e9cifique. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">MDx peut-il prendre en charge la documentation technique des DIV et des dispositifs m\u00e9dicaux dans le m\u00eame projet ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Oui. Nous disposons d\u2019\u00e9quipes sp\u00e9cialis\u00e9es pour les   <\/span><a href=\"https:\/\/mdxcro.com\/sectors\/ivd-end-to-end\/\"><span style=\"font-weight: 400\">DIV<\/span><\/a><span style=\"font-weight: 400\"> et les <\/span><a href=\"https:\/\/mdxcro.com\/sectors\/medical-devices\/\"><span style=\"font-weight: 400\">dispositifs m\u00e9dicaux<\/span><\/a><span style=\"font-weight: 400\">, avec des experts dans des domaines technologiques sp\u00e9cifiques tels que les logiciels, les produits combin\u00e9s et les diagnostics compagnons. Pour les produits comportant les deux composants, nous fournissons un soutien int\u00e9gr\u00e9 avec des \u00e9quipes travaillant en parall\u00e8le. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Quels avantages les anciens examinateurs d\u2019organismes notifi\u00e9s apportent-ils \u00e0 l\u2019\u00e9laboration de la documentation technique ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Nos anciens experts d\u2019ON comprennent exactement comment les soumissions sont examin\u00e9es, les d\u00e9ficiences courantes et ce qui constitue une preuve acceptable. Cette connaissance interne garantit que la documentation est structur\u00e9e de mani\u00e8re optimale, r\u00e9pondant aux pr\u00e9occupations potentielles avant qu\u2019elles ne deviennent des constatations. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Comment restez-vous au courant de l\u2019\u00e9volution des exigences r\u00e9glementaires ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Notre \u00e9quipe de veille r\u00e9glementaire surveille en permanence les mises \u00e0 jour des autorit\u00e9s (EMA, FDA, MHRA), des organismes notifi\u00e9s et des groupes industriels. Nous entretenons des relations avec les organismes de r\u00e9glementation, participons \u00e0 des groupes de travail industriels et int\u00e9grons imm\u00e9diatement les nouvelles directives dans nos processus. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Pouvez-vous prendre en charge des soumissions mondiales au-del\u00e0 des march\u00e9s de l\u2019UE et des \u00c9tats-Unis ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Oui. Nous prenons en charge les soumissions sur les march\u00e9s majeurs et \u00e9mergents du monde entier, notamment au Royaume-Uni, au Canada, en Australie, au Japon, au Br\u00e9sil et en Chine. Notre strat\u00e9gie r\u00e9glementaire mondiale garantit une exploitation efficace de la documentation de base pour plusieurs march\u00e9s.  <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                          <li class=\"faq-item\">\n                <div class=\"faq-question\">Quelle est votre approche de la documentation de conformit\u00e9 GSPR ?<\/div>\n                <div class=\"faq-answer\">\n                  <div class=\"faq-answer-inner wysiwyg\">\n                    <p><span style=\"font-weight: 400\">Nous suivons une approche syst\u00e9matique de la conformit\u00e9 GSPR, en cartographiant les exigences applicables, en identifiant les normes pertinentes, en \u00e9valuant la conformit\u00e9 \u00e0 chaque exigence et en documentant les preuves. Notre approche garantit une tra\u00e7abilit\u00e9 compl\u00e8te entre les exigences, les normes et les preuves de v\u00e9rification. <\/span><\/p>\n                  <\/div>\n                <\/div>\n              <\/li>\n                      <\/ul>\n              <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n  <script type=\"application\/ld+json\">\n    {\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Combien de temps faut-il g\u00e9n\u00e9ralement pour remettre \u00e0 niveau la documentation technique pour la conformit\u00e9 RDM\/RDIV ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Les d\u00e9lais varient en fonction de la classe du dispositif et de la maturit\u00e9 de la documentation, mais se situent g\u00e9n\u00e9ralement entre 3 et 8 mois pour une remise \u00e0 niveau compl\u00e8te de la documentation technique. Notre phase d\u2019\u00e9valuation fournit un calendrier pr\u00e9cis pour votre produit sp\u00e9cifique.\"}},{\"@type\":\"Question\",\"name\":\"MDx peut-il prendre en charge la documentation technique des DIV et des dispositifs m\u00e9dicaux dans le m\u00eame projet ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui. Nous disposons d\u2019\u00e9quipes sp\u00e9cialis\u00e9es pour les   DIV et les dispositifs m\u00e9dicaux, avec des experts dans des domaines technologiques sp\u00e9cifiques tels que les logiciels, les produits combin\u00e9s et les diagnostics compagnons. Pour les produits comportant les deux composants, nous fournissons un soutien int\u00e9gr\u00e9 avec des \u00e9quipes travaillant en parall\u00e8le.\"}},{\"@type\":\"Question\",\"name\":\"Quels avantages les anciens examinateurs d\u2019organismes notifi\u00e9s apportent-ils \u00e0 l\u2019\u00e9laboration de la documentation technique ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nos anciens experts d\u2019ON comprennent exactement comment les soumissions sont examin\u00e9es, les d\u00e9ficiences courantes et ce qui constitue une preuve acceptable. Cette connaissance interne garantit que la documentation est structur\u00e9e de mani\u00e8re optimale, r\u00e9pondant aux pr\u00e9occupations potentielles avant qu\u2019elles ne deviennent des constatations.\"}},{\"@type\":\"Question\",\"name\":\"Comment restez-vous au courant de l\u2019\u00e9volution des exigences r\u00e9glementaires ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Notre \u00e9quipe de veille r\u00e9glementaire surveille en permanence les mises \u00e0 jour des autorit\u00e9s (EMA, FDA, MHRA), des organismes notifi\u00e9s et des groupes industriels. Nous entretenons des relations avec les organismes de r\u00e9glementation, participons \u00e0 des groupes de travail industriels et int\u00e9grons imm\u00e9diatement les nouvelles directives dans nos processus.\"}},{\"@type\":\"Question\",\"name\":\"Pouvez-vous prendre en charge des soumissions mondiales au-del\u00e0 des march\u00e9s de l\u2019UE et des \u00c9tats-Unis ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Oui. Nous prenons en charge les soumissions sur les march\u00e9s majeurs et \u00e9mergents du monde entier, notamment au Royaume-Uni, au Canada, en Australie, au Japon, au Br\u00e9sil et en Chine. Notre strat\u00e9gie r\u00e9glementaire mondiale garantit une exploitation efficace de la documentation de base pour plusieurs march\u00e9s.\"}},{\"@type\":\"Question\",\"name\":\"Quelle est votre approche de la documentation de conformit\u00e9 GSPR ?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nous suivons une approche syst\u00e9matique de la conformit\u00e9 GSPR, en cartographiant les exigences applicables, en identifiant les normes pertinentes, en \u00e9valuant la conformit\u00e9 \u00e0 chaque exigence et en documentant les preuves. Notre approche garantit une tra\u00e7abilit\u00e9 compl\u00e8te entre les exigences, les normes et les preuves de v\u00e9rification.\"}}]}  <\/script>\n\n<section id=\"block_451042820cff1aefbae06843d51ddb0f\" class=\"call-to-action\" style=\"padding-top: Par d\u00e9faut; padding-bottom: Par d\u00e9faut; margin-top: Par d\u00e9faut; margin-bottom: Par d\u00e9faut; \">\n        <div class=\"call-to-action--bg\">\n      <img decoding=\"async\" src=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/08\/mdx-cta-bg.png\" alt=\"\" \/>\n    <\/div>\n    <div class=\"container\">\n        <div class=\"grid\">\n            <div class=\"content\">\n                                    <h2 class=\"title\">Une documentation technique experte pour votre succ\u00e8s r\u00e9glementaire<\/h2>\n                \n                                    <div class=\"description wysiwyg\">\n                        <p><span style=\"font-weight: 400;\">Que vous soyez confront\u00e9 \u00e0 la transition RDIV\/RDM, que vous pr\u00e9pariez une soumission \u00e0 un organisme notifi\u00e9 ou que vous d\u00e9veloppiez une strat\u00e9gie r\u00e9glementaire mondiale, MDx apporte l\u2019expertise et l\u2019ex\u00e9cution dont vous avez besoin pour naviguer dans les exigences avec confiance et efficacit\u00e9.<\/span><\/p>\n<p><b>Du concept \u00e0 la conformit\u00e9. Nous assurons. <\/b><\/p>\n                    <\/div>\n                            <\/div>\n\n                            <div class=\"button-wrapper\">\n                                                                        <a href=\"https:\/\/mdxcro.com\/fr\/contact\/?utm_source=ra_tech_doc\" class=\"button bouton--secondaire\" target=\"\">\n                                R\u00e9server une \u00e9valuation r\u00e9glementaire                            <\/a>\n                                                            <\/div>\n                    <\/div>\n    <\/div>\n<\/section>\n\n<script type=\"application\/ld+json\">{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"Service\",\n  \"serviceType\": \"Regulatory Affairs and Technical Documentation for Medical Devices\",\n  \"provider\": {\n    \"@type\": \"Organization\",\n    \"name\": \"MDx CRO\",\n    \"url\": \"https:\/\/www.mdxcro.com\",\n    \"logo\": \"https:\/\/www.mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg\"\n  },\n  \"areaServed\": [\n    {\n      \"@type\": \"Place\",\n      \"name\": \"European Union\"\n    },\n    {\n      \"@type\": \"Place\", \n      \"name\": \"United States\"\n    },\n    {\n      \"@type\": \"Place\",\n      \"name\": \"Asia\"\n    }\n  ],\n  \"audience\": {\n    \"@type\": \"Audience\",\n    \"audienceType\": \"US and Asian medical device companies seeking European market access\"\n  },\n  \"description\": \"Expert regulatory affairs consulting for MDR, IVDR, and EU medical device compliance. Supporting international companies entering European markets with complete technical documentation, notified body submissions, and regulatory strategy.\",\n  \"hasOfferCatalog\": {\n    \"@type\": \"OfferCatalog\",\n    \"name\": \"Regulatory Affairs Services\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"Offer\",\n        \"itemOffered\": {\n          \"@type\": \"Service\",\n          \"name\": \"MDR\/IVDR Compliance Strategy\"\n        }\n      },\n      {\n        \"@type\": \"Offer\",\n        \"itemOffered\": {\n          \"@type\": \"Service\",\n          \"name\": \"Technical Documentation Development\"\n        }\n      },\n      {\n        \"@type\": \"Offer\",\n        \"itemOffered\": {\n          \"@type\": \"Service\",\n          \"name\": \"Notified Body Submission Support\"\n        }\n      },\n      {\n        \"@type\": \"Offer\",\n        \"itemOffered\": {\n          \"@type\": \"Service\",\n          \"name\": \"Clinical Evaluation Reports (CER)\"\n        }\n      },\n      {\n        \"@type\": \"Offer\",\n        \"itemOffered\": {\n          \"@type\": \"Service\",\n          \"name\": \"EUDAMED Registration\"\n        }\n      }\n    ]\n  },\n  \"offers\": {\n    \"@type\": \"AggregateOffer\",\n    \"availability\": \"https:\/\/schema.org\/InStock\",\n    \"priceSpecification\": {\n      \"@type\": \"PriceSpecification\",\n      \"priceCurrency\": \"EUR\",\n      \"price\": \"Contact for quote\"\n    }\n  }\n}\n<\/script>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-11862","service","type-service","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV<\/title>\n<meta name=\"description\" content=\"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV\" \/>\n<meta property=\"og:description\" content=\"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/\" \/>\n<meta property=\"og:site_name\" content=\"MDx CRO\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-24T09:50:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/\",\"name\":\"Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\",\"datePublished\":\"2025-07-30T07:27:27+00:00\",\"dateModified\":\"2026-06-24T09:50:32+00:00\",\"description\":\"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/check-white-1.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/services\\\/affaires-reglementaires-documentation-technique\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affaires r\u00e9glementaires et documentation technique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\",\"name\":\"MDx CRO\",\"description\":\"MedTech &amp; IVD Clinical Research, Regulatory &amp; QA\",\"publisher\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#organization\"},\"alternateName\":\"MDx\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#organization\",\"name\":\"MDx CRO\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"contentUrl\":\"https:\\\/\\\/mdxcro.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/MDX.svg\",\"width\":352,\"height\":114,\"caption\":\"MDx CRO\"},\"image\":{\"@id\":\"https:\\\/\\\/mdxcro.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/medtech-ivd-cro\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV","description":"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/","og_locale":"fr_FR","og_type":"article","og_title":"Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV","og_description":"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.","og_url":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/","og_site_name":"MDx CRO","article_modified_time":"2026-06-24T09:50:32+00:00","og_image":[{"url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/","url":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/","name":"Conseil en r\u00e9glementation des DIV et documentation technique | RDM et RDIV","isPartOf":{"@id":"https:\/\/mdxcro.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/#primaryimage"},"image":{"@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/#primaryimage"},"thumbnailUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","datePublished":"2025-07-30T07:27:27+00:00","dateModified":"2026-06-24T09:50:32+00:00","description":"Conseil en affaires r\u00e9glementaires de bout en bout pour les fabricants de DIV et de dispositifs m\u00e9dicaux. Documentation technique RDM et RDIV, strat\u00e9gie de marquage CE et soumission aux organismes notifi\u00e9s.","breadcrumb":{"@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/#primaryimage","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/check-white-1.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/mdxcro.com\/fr\/services\/affaires-reglementaires-documentation-technique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdxcro.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Affaires r\u00e9glementaires et documentation technique"}]},{"@type":"WebSite","@id":"https:\/\/mdxcro.com\/fr\/#website","url":"https:\/\/mdxcro.com\/fr\/","name":"MDx CRO","description":"MedTech &amp; IVD Clinical Research, Regulatory &amp; QA","publisher":{"@id":"https:\/\/mdxcro.com\/fr\/#organization"},"alternateName":"MDx","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdxcro.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mdxcro.com\/fr\/#organization","name":"MDx CRO","url":"https:\/\/mdxcro.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mdxcro.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","contentUrl":"https:\/\/mdxcro.com\/wp-content\/uploads\/2025\/07\/MDX.svg","width":352,"height":114,"caption":"MDx CRO"},"image":{"@id":"https:\/\/mdxcro.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/medtech-ivd-cro"]}]}},"_links":{"self":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/service\/11862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/service"}],"about":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/types\/service"}],"wp:attachment":[{"href":"https:\/\/mdxcro.com\/fr\/wp-json\/wp\/v2\/media?parent=11862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}